Stella Diagnostics (Stella Diagnostics) Enterprise Value : $23.66 Mil (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Stella Diagnostics's Enterprise Value is $23.66 Mil. Stella Diagnostics does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's EV-to-EBIT at this moment.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Stella Diagnostics's Enterprise Value is $23.66 Mil. Stella Diagnostics does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's EV-to-EBITDA at this moment.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Stella Diagnostics's Enterprise Value is $23.66 Mil. Stella Diagnostics does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's EV-to-Revenue at this moment.

Stella Diagnostics Enterprise Value Historical Data

The historical data trend for Stella Diagnostics's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Enterprise Value Chart

Stella Diagnostics Annual Data

Trend

Enterprise Value

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Enterprise Value	11.76	45.51

Competitive Comparison of Stella Diagnostics's Enterprise Value

For the Diagnostics & Research subindustry, Stella Diagnostics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's Enterprise Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's Enterprise Value falls into.

Stella Diagnostics Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Stella Diagnostics's Enterprise Value for the fiscal year that ended in . 20 is calculated as

	Enterprise Value (A: . 20 )
=	Market Cap	+	Preferred Stock	+	Long-Term Debt & Capital Lease Obligation
=		+		+
+	Short-Term Debt & Capital Lease Obligation	+	Minority Interest	-	Cash, Cash Equivalents, Marketable Securities
+		+		-
=	0.00

Stella Diagnostics's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

	Enterprise Value (Q: Sep. 2023 )
=	Market Cap	+	Preferred Stock	+	Long-Term Debt & Capital Lease Obligation
=	40.16	+	3.905	+	0.798
+	Short-Term Debt & Capital Lease Obligation	+	Minority Interest	-	Cash, Cash Equivalents, Marketable Securities
+	0.648	+	0	-	0.002
=	45.51

Stella Diagnostics (OTCPK:SLDX) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

Stella Diagnostics Enterprise Value Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Enterprise Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.